共 9 条
- [1] OVER TWO AND A HALF YEARS LONGITUDINAL ANALYSIS OF SIX MONTH SUBCUTANEOUS LEUPROLIDE ACETATE TREATMENT FOR PUBERTAL SUPPRESSION IN THREE BOYS HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 104 - 105
- [2] Two years of clinical experience with six month subcutaneous leuprolide acetate for central precocious puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 77
- [3] Two years of clinical experience with six month subcutaneous leuprolide acetate for central precocious puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2024, 77 : 241 - 242
- [4] Clinical experience with 6-month subcutaneous leuprolide acetate for central precocious puberty JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2023, 72 : 202 - 203
- [6] 36-Month Treatment Experience of Two Doses of Leuprolide Acetate 3-Month Depot for Children With Central Precocious Puberty JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (09): : 3153 - 3159
- [7] 6-Month Subcutaneous Leuprolide Acetate Achieved and Maintained Hormonal and Clinical Suppression in All Weight Groups of Children with Central Precocious Puberty HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 3): : 285 - 287
- [9] A 12-month clinical study of LA-2585 (45.0 MG): A new 6-month subcutaneous delivery system for Leuprolide acetate for the treatment of prostate cancer JOURNAL OF UROLOGY, 2006, 175 (02): : 533 - 536